UMIN-CTR Clinical Trial

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Recruitment status Enrolling by invitation
Unique ID issued by UMIN UMIN000040344
Receipt No. R000046039
Scientific Title Effect of anti-histamine eye drops on pupil diameter
Date of disclosure of the study information 2020/05/09
Last modified on 2020/11/27

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Public title Effect of anti-histamine eye drops on pupil diameter
Acronym Effect of anti-histamine eye drops on pupil diameter
Scientific Title Effect of anti-histamine eye drops on pupil diameter
Scientific Title:Acronym Effect of anti-histamine eye drops on pupil diameter
Region
Japan

Condition
Condition Patients who are prescribed epinastine hydrochloride eye-drops and have a funds examination.
Classification by specialty
Ophthalmology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To evaluate the effect of epinastine hydrochloride eye-drops on pupil diameter
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Comparison among the pupil diameter of original pupil, after instillation of Tropicamide Phenylephrine hydrochloride (TPH), and after instillation of TPH and Epinastine hydrochloride eye-drops.
Key secondary outcomes

Base
Study type Observational

Study design
Basic design
Randomization
Randomization unit
Blinding
Control
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms
Purpose of intervention
Type of intervention
Interventions/Control_1
Interventions/Control_2
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
20 years-old <=
Age-upper limit
80 years-old >
Gender Male and Female
Key inclusion criteria The patient who does not meet exclusion criteria.
Key exclusion criteria 1.Iris atrophy, macular disease, corneal opacity, shallow anterior chamber or cataract with Emery-Little classification 3 or higher.

2. Existing diagnosis of cardiovascular disease.

3. A history of allergy to mydriatic drugs
4. Those who are being treated with eye drops due to glaucoma
Target sample size 70

Research contact person
Name of lead principal investigator
1st name Hitoshi
Middle name
Last name Ishikawa
Organization Kitasato University
Division name Department of Orthoptics and Visual Science, School of Allied Health Sciences
Zip code 252-0373
Address 1-15-1 Kitasato, Minami-ku, Sagamihara Kanagawa
TEL 0427789671
Email hitoshi@kitasato-u.ac.jp

Public contact
Name of contact person
1st name Kazunori
Middle name Hirasawa
Last name Hirasawa
Organization Kitasato University
Division name Department of Ophthalmology, School of Medicine
Zip code 252-0373
Address 1-15-1 Kitasato, Minami-ku, Sagamihara Kanagawa
TEL 0427788464
Homepage URL
Email hirasawa@kitasato-u.ac.jp

Sponsor
Institute Kitasato University
Institute
Department

Funding Source
Organization Kitasato University, research grant
Organization
Division
Category of Funding Organization Self funding
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

IRB Contact (For public release)
Organization Kitasato University Hospital Ethics Committee
Address 1-15-1 Kitasato, Minami-ku, Sagamihara Kanagawa
Tel 042-778-8273
Email rinrib@med.kitasato-u.ac.jp

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2020 Year 05 Month 09 Day

Related information
URL releasing protocol
Publication of results Unpublished

Result
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results date posted
Results Delayed
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Participant flow
Adverse events
Outcome measures
Plan to share IPD
IPD sharing Plan description

Progress
Recruitment status Enrolling by invitation
Date of protocol fixation
2020 Year 04 Month 10 Day
Date of IRB
2020 Year 07 Month 08 Day
Anticipated trial start date
2020 Year 07 Month 09 Day
Last follow-up date
2023 Year 03 Month 01 Day
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Other
Other related information none

Management information
Registered date
2020 Year 05 Month 09 Day
Last modified on
2020 Year 11 Month 27 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000046039

Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name


Contact us.